D. N. Samur Et Al. , "Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease," Neuropharmacology , vol.271, 2025
Samur, D. N. Et Al. 2025. Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease. Neuropharmacology , vol.271 .
Samur, D. N., Yıldırım, S., Maytalman, E., Kalay, M., TANRIÖVER, G., & ÖZBEY, G., (2025). Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease. Neuropharmacology , vol.271.
Samur, Dilara Et Al. "Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease," Neuropharmacology , vol.271, 2025
Samur, Dilara N. Et Al. "Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease." Neuropharmacology , vol.271, 2025
Samur, D. N. Et Al. (2025) . "Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease." Neuropharmacology , vol.271.
@article{article, author={Dilara Nemutlu Samur Et Al. }, title={Vortioxetine attenuates rotenone-induced enteric neuroinflammation via modulation of the TLR2/S100B/RAGE signaling pathway in a rat model of Parkinson's disease}, journal={Neuropharmacology}, year=2025}